Latest Medizone Intl Inc (MZEI) Headlines AsepticSure

New Post Public Reply Private Reply Replies (1) Message Board

Mar 10, 2014 at 5:59 PM

Latest Medizone Intl Inc (MZEI) Headlines

AsepticSure moves closer to US launch as Medizone International's Board of Directors is expanded to add significant Business Development and Strategy Strength
PR Newswire - Thu Feb 27, 8:00AM CST
Medizone International, Inc. (MZEI:OB MZEI:QB) announces the addition of David Esposito to the Board of Directors. Medizone makes this move in anticipation of full US regulatory approval of the Company's AsepticSure® hospital disinfection system.

Medizone International Inc wins US patent for AsepticSure for the elimination of Anthrax in critical buildings, infrastructure and resources following biological attack
M2 - Thu Jan 30, 5:25AM CST
Disinfection systems company Medizone International Inc (MZEI:OB)(MZEI:QB) reported on Wednesday the receipt of its fourth patent for its revolutionary enclosed space room disinfection system, AsepticSure, for the elimination of Anthrax.

Patent Protection Granted For The Elimination of Anthrax
PR Newswire - Wed Jan 29, 7:35AM CST
Medizone International, Inc. (The Company) (MZEI:OB, MZEI:QB) has just been granted its fourth patent for its revolutionary enclosed space room disinfection system, AsepticSure. The United States Patent and Trademark Office has issued US Patent number 8,636,951 titled BIO-TERRORISM COUNTERACTION USING OZONE AND HYDROGEN PEROXIDE.

Emerging Hospital Room Disinfection System Should Save Billions
PR Newswire - Thu Jan 23, 7:35AM CST
Medizone International, Inc. (MZEI:OB, MZEI:QB). In what is believed to be an important first, an entire ward at a public hospital remains 100% free from MRSA for 6 months after a major outbreak is quashed - thanks to the introduction of a new hospital room disinfection technology.

Medizone's AsepticSure hospital disinfection technology awarded US Patent
M2 - Wed Oct 09, 4:38AM CDT
Medizone International Inc (OTCBB:MZEI) announced yesterday that AsepticSure, its WHO award-winning green infection control technology, has been granted a patent by the US Patent and Trademark office under patent number US 61/223,219 entitled 'Healthcare Facility Disinfecting System'.

AsepticSure Hospital Disinfection Technology Receives US Patent Protection
PR Newswire - Tue Oct 08, 7:35AM CDT
Medizone International, Inc. (MZEI:OB, MZEI:QB) is pleased to announce that its WHO award-winning green infection control technology, AsepticSure® has been Granted a patent by the United States Patent and Trademark office. (US 61/223,219) titled "Healthcare Facility Disinfecting System". The AsepticSure infection control system has repeatedly demonstrated 100% microbial kill rates when used to decontaminate hospital rooms of the causative agents of HAI (hospital acquired infections).

OTC Daily Alert Stock Watch - Medizone International, Inc. (OTCQB: MZEI)
WorldStockWire - Fri Sep 06, 6:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

New Ozone-Based Disinfection Technology Eradicates MRSA From Infected Hospital Rooms - In Less Than 60 Minutes
PR Newswire - Tue Jul 09, 7:35AM CDT
San Francisco-based Medizone International (MZEI:OB MZEI:QB), is pleased to announce that it is using its AsepticSure system at the Quinte Health Care-Belleville General Hospital as part of the hospital's management of a recent outbreak of MRSA (Methicilllin-Resistant Staphylococcus Aureus) infections there. This move comes in the wake of Medizone having previously disinfected several patient care rooms at the facility in as little as 40 minutes treatment-time per room.

Medizone signs distribution agreement in Canada for AsepticSure to enter hospital market
M2 - Tue Apr 16, 8:16AM CDT
Medizone International Inc (OTCBB:MZEI:OB), the manufacturer of AsepticSure hospital disinfection systems, and Wood Wyant Canada announced on Monday that Wood Wyant, a Canadian distributor of sanitation products, has become a national hospital distributor of AsepticSure in Canada.

AsepticSure Distribution Agreement Opens Door To Canadian Hospital Market
CNW Group - Mon Apr 15, 7:38AM CDT
Hospital disinfection technology, AsepticSure, to be distributed nation-wide by Wood Wyant, Canada's largest distributor of sanitation products

Medizone and Wood Wyant signs AsepticSure distribution agreement for Canada
M2 - Fri Apr 12, 8:56AM CDT
Medizone International Inc (OTCBB:MZEI:OB), the manufacturer of AsepticSure hospital disinfection systems, and Wood Wyant Canada, a subsidiary of Sanimarc Group and a large distributor of sanitation products in Canada, on Thursday jointly announced that Wood Wyant has become a National Hospital Distributor of AsepticSure in Canada.

Medizone International Inc to launch AsepticSure in Canadian hospital market
M2 - Fri Apr 12, 6:57AM CDT
Medizone International Inc (MZEI:OB) (MZEI:QB) reported on Thursday that Wood Wyant is the national hospital distributor of the former's AsepticSure in Canada.

AsepticSure Disinfection System Proving Successful In Canadian Hospital Trials
PR Newswire - Thu Feb 14, 7:35AM CST
San Francisco-based Medizone International (MZEI:OB MZEI:QB), announced today the successful completion of safety and preliminary operational trials of its AsepticSure system at Quinte Health Care Belleville General Hospital, affiliated with Queen's University.

Singapore Patent Opens Door to Asia For Revolutionary Hospital Disinfection Technology
PR Newswire - Wed Feb 06, 7:35AM CST
Medizone International (MZEI:OB MZEI:QB), developers of AsepticSure - a unique room disinfection system capable of obtaining sustained > 6 log (> 99.9999%) broad spectrum bactericidal kill rates in a health care setting - announced today that Singapore has joined Canada in Granting a patent for its international award-winning technology. (Singapore Patent P-No.: 176977 Healthcare Facility Disinfecting Process and System With Oxygen/Ozone Mixture)

Medizone International, Inc. (MZEIQ) Stock Research Links

MZEIQ Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DeFi Technologies Gains More Time for Nasdaq Compliance

DeFi Must Step Up To Meet Compliance Challenge Alright, folks, here's the scoop: DeFi Technologies just picked up another 180 days from Nasdaq to get its act together and hit that crucial one-buck minimum bid price. It's like getting extra time on a pop quiz you forgot to study for—useful, but no guarantee they'll pass. What Led to the Extra Time? These guys over at...

NOVOSENSE's Bold Performance Amid Rapid IC Demand

Surge in Revenue Growth Marks a Milestone for NOVOSENSE Give a pat on the back to NOVOSENSE (HKEX: 02676), because reporting a robust 66.73% bump in first-half revenue isn't small potatoes in today's tech landscape. This translates to around $374.54 million rolling into their coffers, which is quite a spectacle if you're watching the trend of sequential revenue growth...

FirstEnergy's Bold Move: Dormo Joins to Boost Power

Changing the Game in Power Generation In the ever-shifting landscape of power generation, having a seasoned player at the helm can be the difference between stagnation and growth. FirstEnergy Corp. (NYSE:FE) has tapped Jon Dormo as its Vice President of Generation Project Development. The mission? Overhaul and expand projects to meet the increasing demands for...

Smithfield's Foreign Lobbying Interests Unveiled Amid Uproar

A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...

TECNO Unleashes New Laptops & Phones at IFA 2026

A Bold Leap by TECNO You walk into the IFA ShowStoppers 2026 event, and what’s greeting you is a flashy splash of next-gen tech from TECNO. Now, if you thought this brand was only about pushing phones, you're in for a ride. TECNO has crashed the laptop party with its new MEGABOOK T15 360 Series, showing it’s more than capable of straddling the tablet and laptop worlds...

Russo Pushes $100M Boost for Women Entrepreneurs in FL

Russo's Big Bet on Women-led Ventures There's nothing quite like a political shake-up promising to dig into government pockets without slamming taxpayers. Frank Russo, tossing his hat for Florida's governorship, is betting big on women entrepreneurs with a bold move—a $100 million Women’s Entrepreneurship Initiative. No new taxes, he claims, just smart financial...

EzCheckPrinting Boosts Remote Check Solutions Cost-Effectively

Navigating the Check Printing Landscape Let's dive right into the changing realities of the workspace. With remote work becoming the new standard, small businesses are juggling tighter budgets while trying to maintain smooth financial operations. It's a hard game, but here is where Halfpricesoft.com rolls out their newly upgraded multi-user ezCheckPrinting software,...

VT Markets Appoints Maxwell for Global Expansion

Maxwell Joins VT Markets Amid Strategic Shift Forget the usual humdrum of C-suite comings and goings; this one's packed with punch. VT Markets is setting the stage for a serious leap forward by naming Ross Maxwell their new Chief Strategy Officer. This isn't just another desk job—it's a pivotal role meant to integrate cutting-edge technology with the ever-evolving...

Art and Science Blend in Dr. De La Cruz's Approach

Redefining Aesthetic Surgery: An Artistic Approach The world of plastic surgery is often seen through the lens of beauty and symmetry, but for Dr. Emmanuel De La Cruz, it's like staring into a whole different universe. This Houston-based plastic surgeon isn't just removing fat—he's reshaping the human canvas with the eye of a sculptor. Beyond the Standard Cut and Snip...

Argo Biopharma's BW-20805 Shows Promise in HAE Phase II Trial

Argo's Gains in Hereditary Angioedema Therapy Think about it, folks – reducing a hereditary angioedema attack by over 80%? Argo Biopharma, the slick operator in the RNA therapeutics space, is flexing its muscles again. They've hauled in some impressive data for their siRNA therapeutic, BW-20805, at the 2026 Bradykinin Symposium in Berlin. For you deep-pocketed investors...